Advertisement
Advertisement
EOLS
Evolus, Inc. Common Stock
6.36
USDSponsored
-0.03
-0.47%
May 08, 16:00 UTC -4
Closed
Pre-Market
6.31
-0.05
-0.79%
EOLS Earnings Reports
Positive Surprise Ratio
EOLS beat 21 of 34 last estimates.
62%
Next Report
Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$83.77M
/-$0.04
Implied change from Q1 26 (Revenue/ EPS)
+14.53%
/-60.00%
Implied change from Q2 25 (Revenue/ EPS)
+20.73%
/-82.61%
Evolus, Inc. Common Stock earnings per share and revenue
On May 04, 2026, EOLS reported earnings of -0.10 USD per share (EPS) for Q1 26, beating the estimate of -0.13 USD, resulting in a 24.59% surprise. Revenue reached 73.14 million, compared to an expected 73.73 million, with a -0.81% difference. The market reacted with a +14.16% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.04 USD, with revenue projected to reach 83.77 million USD, implying an decrease of -60.00% EPS, and increase of 14.53% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
BioLife Solutions Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.02
Actual
$0.04
Surprise
+96.08%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.04
Actual
$0.01
Surprise
+120.79%
Varex Imaging Corporation Common Stock
Report Date
May 07, 2026 For Q2 26
Estimate
$0.21
Actual
$0.21
Surprise
-1.82%
InfuSystem Holdings, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.03
Actual
$0.05
Surprise
+46.63%
Apyx Medical Corporation Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.05
Surprise
+53.75%
Lantheus Holdings, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.26
Actual
$1.46
Surprise
+15.85%
ICU Medical Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.78
Actual
$1.97
Surprise
+10.26%
Haemonetics Corporation
Report Date
May 07, 2026 For Q4 26
Estimate
$1.28
Actual
$1.29
Surprise
+0.42%
Rockwell Medical, Inc. (DE) Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.04
Surprise
-56.86%
Nephros Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.01
Actual
$0.01
Surprise
-1.96%
FAQ
What were Evolus, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Evolus, Inc. Common Stock reported EPS of -$0.10, beating estimates by 24.59%, and revenue of $73.14M, -0.81% below expectations.
How did the market react to Evolus, Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 14.16%, changed from $5.58 before the earnings release to $6.37 the day after.
When is Evolus, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 03, 2026.
What are the forecasts for Evolus, Inc. Common Stock's next earnings report?
Based on 5
analysts, Evolus, Inc. Common Stock is expected to report EPS of -$0.04 and revenue of $83.77M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement